Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
Yesenia L Franco,* Tanaya R Vaidya,* Sihem Ait-Oudhia Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA *These authors contributed equally to this work Abstract: Breast cancer (BC) is a highly prevalent dise...
Main Authors: | Franco YL, Vaidya TR, Ait-Oudhia S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/anticancer-and-cardio-protective-effects-of-liposomal-doxorubicin-in-t-peer-reviewed-article-BCTT |
Similar Items
-
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
by: Hamidreza Dorostkar, et al.
Published: (2023-07-01) -
Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy
by: Ping Huang, et al.
Published: (2022-08-01) -
Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
by: Huang, Bu-Wei, et al.
Published: (2018) -
Maleimide-Functionalized Liposomes: Prolonged Retention and Enhanced Efficacy of Doxorubicin in Breast Cancer with Low Systemic Toxicity
by: Chuane Tang, et al.
Published: (2022-07-01) -
Neoadjuvant Combination Chemotherapy with Pegylated Liposomal Doxorubicin and Vinorelbine for Locally Advanced Breast Cancer
by: Zhen-zhou SHEN, et al.
Published: (2010-02-01)